Sales rise 35.21% to Rs 3.84 crore
Net Loss of Brawn Biotech reported to Rs 0.43 crore in the quarter ended December 2024 as against net loss of Rs 0.61 crore during the previous quarter ended December 2023. Sales rose 35.21% to Rs 3.84 crore in the quarter ended December 2024 as against Rs 2.84 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales3.842.84 35 OPM %-10.42-20.42 -PBDT-0.40-0.58 31 PBT-0.43-0.61 30 NP-0.43-0.61 30Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
